查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933362

全球家禽疫苗市场：市场规模、占有率、成长率、产业分析、类型、应用及区域分析、未来预测（2026-2034）

Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

家禽疫苗市场成长因素

预计2025年全球家禽疫苗市场规模将达13.2亿美元，2026年将达13.8亿美元。预计到2034年将成长至23.8亿美元，预测期内复合年增长率（CAGR）为6.99%。主要成长因素包括家禽产品需求的成长、禽流感、新城疫和传染性支气管炎等家禽传染病发病率的上升，以及家禽养殖户生物安全和疾病预防意识的提高。 到2025年，北美将以46.11%的市场占有率主导市场，这得益于严格的监管、完善的家禽医疗保健基础设施以及主要疫苗生产商的存在。诸如硕腾服务有限公司（Zoetis Services LLC）、默克公司（Merck & Co., Inc.）和勃林格殷格翰国际有限公司（Boehringer Ingelheim International GmbH）等领先企业凭藉其丰富的产品组合和广泛的地域覆盖，已确立了稳固的市场地位。

市场动态

驱动因素：家禽疫苗市场最重要的驱动因素是全球禽肉和禽蛋消费量的成长。随着人口的增长，对动物性蛋白质的需求也在增加，因此家禽健康管理对于维护食品安全和营养品质至关重要。疫苗接种可以抑制疾病爆发，防止经济损失，并确保家禽产品的稳定供应。 例如，根据美国农业部的数据，2024/2025年度美国鸡肉产量将达到2,134万吨，约占全球产量的21%，凸显了无病家禽群的重要性。

限制因素：疫苗失效和 "疫苗外洩" 是重大的市场挑战。像马立克氏症和禽流感这样快速变异的疾病会降低疫苗的有效性，即使在接种过疫苗的家禽群中，死亡率也可能达到10%至40%。这些失效会促使经济损失、生产者不满以及疫苗推广的延迟。

机会：政府主导的疫苗接种活动提供了成长机会。例如，2025年4月，印度畜牧和乳业部与家禽业合作，提供高致病性禽流感（HPAI）疫苗。 这些努力确保了免疫力的一致性，限制了疾病的爆发，并为市场扩张提供了机会。

挑战：供应链中断和储存问题仍然是重大障碍。家禽疫苗必须在 2–8°C 的温度下储存才能保持效力，但中低收入国家冷链基础设施不足会促使疫苗降解、免疫反应降低和浪费增加。

市场趋势

产业正朝着卵内接种的方向发展，即在孵化第 18 天将疫苗注射到鸡蛋中。这种方法可以实现孵化前免疫，减少操作应激，并确保免疫覆盖的一致性。 HIPRA 和其他公司已在欧洲推出了 "EVANOVO" 等卵内疫苗，体现了大规模家禽养殖作业自动化和效率提升的趋势。

市场区隔分析

依技术分类：市场包括灭活疫苗、减毒活疫苗、重组疫苗等疫苗。灭活疫苗因其在预防疫情爆发方面的有效性以及对动物性蛋白质日益增长的需求而占主导地位。例如，2025年2月，硕腾服务有限公司（Zoetis Services LLC）的H5N2禽流感疫苗获得了美国农业部（USDA）的有条件批准。

依疾病类型分类：病毒性疾病疫苗占最大的市场占有率，用于应对禽流感、新城疫和马立克氏症等威胁。 2024年11月，勃林格殷格翰在印度推出了这些病毒性疾病的三联疫苗，推动了该细分市场的成长。

依给药途径分类：注射疫苗因其剂量精准且免疫反应强而成为主流。 例如，2024年3月，默克公司（Merck & Co.）的鸡用肌注疫苗NOBILIS MULTRIVA REOm获得欧洲批准。

依分销管道：得益于政府支持的疫苗接种计划和积极的兽医服务，兽医诊所在分销中发挥着主导作用。 2025年6月，南非透过兽医管道启动了针对高致病性禽流感（HPAI）的大规模疫苗接种运动。

区域展望

北美：在相关法规、主要产业参与者和强劲的研发投入的支持下，北美有望引领市场，到2025年市场规模将达到6.1亿美元。 2025年4月，美国农业部承诺投入1亿美元用于禽流感疫苗研究。

欧洲：受家禽产品需求成长和生物安全意识提高的推动，预计到2025年，欧洲市场规模将达到3.6亿美元，年增长率为5.97%。

亚太地区：亚太地区仍是全球第三大市场，预计到2025年市场规模将达到1.7亿美元，主要受家禽消费量成长和疫苗接种率提高的推动。

拉丁美洲美洲、中东和非洲：在政府为改善家禽卫生而采取的举措推动下，预计市场将温和增长，到 2025 年分别达到 1.1 亿美元和 6000 万美元。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势
  • 市场挑战

第四章：关键考虑因素

  • 家禽疾病概述：依主要国家和地区划分（2025 年）
  • 监理状况：依主要国家及地区划分（2025）
  • 家禽疾病疫苗接种概述
  • 主要公司新技术应用状况
  • 主要产业趋势（併购、合作等）

第五章 全球家禽疫苗市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依技术分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测：依疾病类型分类
    • 病毒性疾病
      • 禽流感
      • 新城疫
      • 马立克氏症
      • 其他
    • 细菌性疾病疾病
      • 沙门氏菌病
      • 支原体病
      • 其他
    • 寄生虫病
  • 市场分析、洞察与预测：依给药途径
    • 肠外给药
    • 鼻腔给药
    • 其他
  • 市场分析、洞察与预测：依分销管道
    • 兽医院
    • 兽医诊所
    • 药局
    • 其他
  • 市场分析、洞察与预测：依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美家禽疫苗市场分析：洞察与预测 （2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲家禽疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区家禽疫苗市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲家禽疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲家禽疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南非
    • 中东其他地区非洲

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
  • Indian Immunologicals Ltd.
  • HIPRA
Product Code: FBI113875

Growth Factors of poultry vaccines Market

The global poultry vaccines market was valued at USD 1.32 billion in 2025 and is projected to reach USD 1.38 billion in 2026, eventually growing to USD 2.38 billion by 2034, reflecting a CAGR of 6.99% during the forecast period. The market is primarily driven by the rising demand for poultry products, increasing incidences of infectious poultry diseases such as avian influenza, Newcastle disease, and infectious bronchitis, and growing awareness about biosecurity and disease prevention among poultry farmers. North America dominated the market in 2025 with a 46.11% share, supported by stringent regulations, robust healthcare infrastructure for poultry, and the presence of leading vaccine manufacturers. Key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH hold strong market positions due to broad product portfolios and extensive geographic presence.

Market Dynamics

Drivers: The most significant driver of the poultry vaccines market is the increasing consumption of poultry meat and eggs globally. A growing population has led to higher demand for animal-based protein, making flock health critical to maintaining food security and nutritional quality. Vaccination reduces disease outbreaks, prevents economic losses, and ensures a steady supply of poultry products. For instance, as per the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in the U.S. during 2024/2025, accounting for around 21% of global production, highlighting the importance of disease-free flocks.

Restraints: Vaccine failures and "leaky vaccines" pose significant market challenges. Rapidly mutating diseases like Marek's disease and avian influenza can reduce vaccine efficacy, causing flock mortality of 10-40% even in vaccinated populations. These failures result in economic losses, farmer dissatisfaction, and slowed adoption of vaccines.

Opportunities: Government vaccination campaigns offer growth potential. For example, in April 2025, India's Department of Animal Husbandry & Dairying collaborated with the poultry industry to offer vaccines against Highly Pathogenic Avian Influenza (HPAI). Such initiatives ensure uniform immunity coverage, mitigate disease outbreaks, and provide opportunities for market expansion.

Challenges: Supply chain disruptions and storage issues remain critical barriers. Poultry vaccines must be stored at 2-8°C to remain effective, and inadequate cold chain infrastructure in lower-middle-income countries can lead to degradation, poor immune responses, and higher wastage.

Market Trends

The industry is witnessing a shift toward in-ovo vaccination technology, where vaccines are injected into eggs on day 18 of incubation. This method offers immunity before hatching, reduces handling stress, and ensures uniform coverage. Companies like HIPRA have launched in-ovo vaccines such as EVANOVO in Europe, exemplifying this trend toward automation and efficiency in large-scale poultry operations.

Segmentation Analysis

By Technology: The market includes inactivated, live attenuated, recombinant, and other vaccines. Inactivated vaccines dominate due to their effectiveness in preventing outbreaks and growing demand for animal protein. For instance, in February 2025, Zoetis Services LLC received USDA conditional approval for its H5N2 Avian Influenza vaccine.

By Disease Type: Viral disease vaccines hold the largest market share, addressing threats from avian influenza, Newcastle disease, and Marek's disease. Boehringer Ingelheim launched a three-in-one vaccine in India (Nov 2024) for these viral diseases, boosting segment growth.

By Route of Administration: Parenteral vaccines dominate due to precise dosing and stronger immune responses. For example, in March 2024, Merck & Co., Inc. obtained European approval for NOBILIS MULTRIVA REOm for intramuscular use in chickens.

By Distribution Channel: Veterinary hospitals lead in distribution due to government-backed vaccination programs and proactive veterinary services. In June 2025, South Africa launched a mass HPAI vaccination campaign through veterinary channels.

Regional Outlook

North America: Dominates with a USD 0.61 billion market size in 2025, driven by regulations, key industry players, and strong R&D investments. The U.S. Department of Agriculture funded USD 100 million in April 2025 for avian influenza vaccine research.

Europe: Expected to reach USD 0.36 billion in 2025, growing at 5.97%, supported by rising poultry product demand and biosecurity awareness.

Asia Pacific: Holds the third-largest market with USD 0.17 billion in 2025, driven by increasing poultry consumption and vaccine adoption.

Latin America & Middle East & Africa: Moderate growth is projected, with 2025 valuations at USD 0.11 billion and USD 0.06 billion, respectively, supported by government initiatives to improve poultry health.

Competitive Landscape

The market is semi-fragmented, with dominant players including Zoetis Services LLC, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco, Ceva, HIPRA, and Bioveta, a.s. These companies focus on product launches, strategic partnerships, and geographic expansion to maintain their leadership. Key industry developments include Bioveta launching an inactivated vaccine against bacterial pasteurellosis (July 2025) and Virbac acquiring Globion (Oct 2023) to expand its India operations.

Conclusion

The global poultry vaccines market is set to grow from USD 1.32 billion in 2025 to USD 1.38 billion in 2026, reaching USD 2.38 billion by 2034 at a CAGR of 6.99%. Market expansion is fueled by rising poultry consumption, outbreaks of infectious diseases, government vaccination campaigns, and innovations such as in-ovo vaccination. While challenges like vaccine failures and cold chain limitations persist, opportunities in technological advancement, product launches, and strategic government initiatives are likely to sustain market growth. Leading companies' strong R&D focus and portfolio diversification further consolidate their market position.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Viral Diseases
    • Avian Influenza
    • Newcastle Disease
    • Marek's Disease
    • Others
  • Bacterial Diseases
    • Salmonellosis
    • Mycoplasmosis
    • Others
  • Parasitic Diseases

By Route of Administration

  • Parenteral
  • Intranasal
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Poultry Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Viral Diseases
      • 5.2.1.1. Avian Influenza
      • 5.2.1.2. Newcastle Disease
      • 5.2.1.3. Marek's Disease
      • 5.2.1.4. Others
    • 5.2.2. Bacterial Diseases
      • 5.2.2.1. Salmonellosis
      • 5.2.2.2. Mycoplasmosis
      • 5.2.2.3. Others
    • 5.2.3. Parasitic Diseases
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Poultry Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Viral Diseases
      • 7.2.1.1. Avian Influenza
      • 7.2.1.2. Newcastle Disease
      • 7.2.1.3. Marek's Disease
      • 7.2.1.4. Others
    • 7.2.2. Bacterial Diseases
      • 7.2.2.1. Salmonellosis
      • 7.2.2.2. Mycoplasmosis
      • 7.2.2.3. Others
    • 7.2.3. Parasitic Diseases
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Viral Diseases
      • 8.2.1.1. Avian Influenza
      • 8.2.1.2. Newcastle Disease
      • 8.2.1.3. Marek's Disease
      • 8.2.1.4. Others
    • 8.2.2. Bacterial Diseases
      • 8.2.2.1. Salmonellosis
      • 8.2.2.2. Mycoplasmosis
      • 8.2.2.3. Others
    • 8.2.3. Parasitic Diseases
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Viral Diseases
      • 9.2.1.1. Avian Influenza
      • 9.2.1.2. Newcastle Disease
      • 9.2.1.3. Marek's Disease
      • 9.2.1.4. Others
    • 9.2.2. Bacterial Diseases
      • 9.2.2.1. Salmonellosis
      • 9.2.2.2. Mycoplasmosis
      • 9.2.2.3. Others
    • 9.2.3. Parasitic Diseases
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Viral Diseases
      • 10.2.1.1. Avian Influenza
      • 10.2.1.2. Newcastle Disease
      • 10.2.1.3. Marek's Disease
      • 10.2.1.4. Others
    • 10.2.2. Bacterial Diseases
      • 10.2.2.1. Salmonellosis
      • 10.2.2.2. Mycoplasmosis
      • 10.2.2.3. Others
    • 10.2.3. Parasitic Diseases
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA

List of Tables

  • Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2025 & 2034
  • Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2025 & 2034
  • Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2025